Synlogic, Inc. (SYBX)
PNK · Healthcare · Biotechnology
$1.12
+55.56%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$13.1M
Shares Outstanding
11.7M
Exchange
PNK
Currency
USD
About Synlogic, Inc.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -786K | -826K | -1.1M | -1.1M |
| Net Income | -529K | -2.3M | 1.5M | 681K |
| Diluted EPS | $-0.04 | $-0.19 | $nan | $0.05 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 1.2M | 3.4M | 8K | 0.00 |
| Operating Income | -67.4M | -55.2M | -15.8M | -3.5M |
| Net Income | -66.1M | -61.3M | -23.4M | -1.0M |
| Diluted EPS | $-13.83 | $-9.42 | $-1.92 | $-0.08 |